Clinical Trial Update: A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety, efficacy, and molecular effects of delgocitinib cream 20 mg/g in adults with frontal fibrosing alopecia; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontal Fibrosing Alopecia

Drugs mentioned

• Delgocitinib cream 20 mg/g (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Frontal Fibrosing Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-07